Kasparcova, Viera
GlaxoSmithKline (United States)
3 papers on CoChat
Most cited papers
- Verified
Design of amidobenzimidazole STING receptor agonists with systemic activity
Ramanjulu, J. M., Pesiridis, G. S., Yang, J., Concha, N., Singhaus, R., Zhang, S.-Y., Tran, J.-L., Moore, P., Lehmann, S., Eberl, H. C., et al. (2018) · Nature
interferon and immune responsesImmunotherapy and Immune Responses
Cited by 912
- Verified
Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
Berger, S. B., Kasparcova, V., Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Cook, M., Finger, J., Hughes-Earle, A., et al. (2014) · The Journal of Immunology
Cell death mechanisms and regulationNF-κB Signaling Pathways
Cited by 374
- Verified
Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor
Thomson, D. W., Poeckel, D., Zinn, N., Rau, C., Strohmer, K., Wagner, A. J., Graves, A. P., Perrin, J., Bantscheff, M., Duempelfeld, B., et al. (2019) · ACS Medicinal Chemistry Letters
interferon and immune responsesImmune Response and Inflammation
Cited by 103
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free